|
CN107365305A
|
|
One kind is according to piperazine azoles novel crystal forms and preparation method thereof
|
|
CN107353303A
|
|
A kind of preparation method of Fosaprepitant phosphate intermediate
|
|
CN104151259A
|
|
Novel preparation method of (5R, 6S)-5,6-dephenyl -2-morpholinone
|
|
CN103130681A
|
|
Novel method for preparing entacapone
|
|
CN103145604A
|
|
Method for preparing ropinirole key intermediate
|
|
CN103130704A
|
|
Novel method for preparing 4-(2-ethoxy)-1,3-dihydro-2H-indole-2-ketone
|
|
CN102964307A
|
|
Dabigatran etexilate related substance and preparation method thereof
|
|
CN102964258A
|
|
Preparation method of related substance J of metoprolol
|
|
CN102964259A
|
|
Preparation method of related substance E of metoprolol
|
|
CN103539730A
|
|
Preparation methods of 3-[N-(2-pyridyl)-3-amino-4-methylamino benzamido]-ethyl propionate
|
|
CN103524498A
|
|
Method for preparing vilazodone
|
|
CN102911160A
|
|
Method for preparing and purifying dabigatran etexilate intermediate
|
|
CN102875460A
|
|
Method for preparing sorafenib
|
|
CN102659811A
|
|
Method for preparing prasugrel
|
|
CN102675197A
|
|
Method for preparing 4-chlorin-N-methylpyridine-2-formamide serving as sorafenib intermediate
|
|
CN103145664A
|
|
Method of preparing vilazodone intermediate 5-piperazin-2-acyl substituted benzofuran
|
|
CN102807523A
|
|
Method for preparing (2R,4R)-4-methyl-2-pipecolic acid
|
|
CN102329254A
|
|
Method for preparing N-[4-[1-hydroxy-2-[(1-methylethyl)amino]ethyl]methylsulfonyl benzylamine hydrochloride
|
|
CN102250014A
|
|
Method for preparing chiral 1-benzyloxycarbonyl hexahydropyridazine-3-carboxylic acid and chiral 1, 2-dibenzyloxycarbonyl hexahydropyridazine-3-carboxylic acid
|
|
CN102212040A
|
|
Novel preparation method for chiral 2-hydroxymethyl morpholine compounds
|
